How much do we pay for a benefit? A descriptive cost analysis of the use of statins. The need for a national cost-effectiveness analysis.
Vieira
J L
JL
Instituto de Cardiologia do Rio Grande do Sul/Fundação Universitária de Caridologia, Porto Alegre, RS, Brazil.
Portal
V L
VL
Moriguchi
E H
EH
D000924:Anticholesteremic Agents / Q000191:economics*; D001938:Brazil; D003362:Cost-Benefit Analysis; D006331:Heart Diseases / Q000191:economics* / Q000517:prevention & control; D006801:Humans; D006937:Hypercholesterolemia / Q000191:economics* / Q000517:prevention & control
D000924:Anticholesteremic Agents